<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30075025</PMID><DateCompleted><Year>2019</Year><Month>01</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>13</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1553-7374</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>8</Issue><PubDate><Year>2018</Year><Month>Aug</Month></PubDate></JournalIssue><Title>PLoS pathogens</Title><ISOAbbreviation>PLoS Pathog</ISOAbbreviation></Journal><ArticleTitle>A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism.</ArticleTitle><Pagination><StartPage>e1007190</StartPage><MedlinePgn>e1007190</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e1007190</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.ppat.1007190</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) causes hand, foot and mouth disease, a mild and self-limited illness that is sometimes associated with severe neurological complications. EV71 neurotropic determinants remain ill-defined to date. We previously identified a mutation in the VP1 capsid protein (L97R) that was acquired over the course of a disseminated infection in an immunocompromised host. The mutation was absent in the respiratory tract but was present in the gut (as a mixed population) and in blood and cerebrospinal fluid (as a dominant species). In this study, we demonstrated that this mutation does not alter the dependence of EV71 on the human scavenger receptor class B2 (SCARB2), while it enables the virus to bind to the heparan sulfate (HS) attachment receptor and modifies viral tropism in cell lines and in respiratory, intestinal and neural tissues. Variants with VP197L or VP197R were able to replicate to high levels in intestinal and neural tissues and, to a lesser extent, in respiratory tissues, but their preferred entry site (from the luminal or basal tissue side) differed in respiratory and intestinal tissues and correlated with HS expression levels. These data account for the viral populations sequenced from the patient's respiratory and intestinal samples and suggest that improved dissemination, resulting from an acquired ability to bind HS, rather than specific neurotropism determinants, enabled the virus to reach and infect the central nervous system. Finally, we showed that iota-carrageenan, a highly sulfated polysaccharide, efficiently blocks the replication of HS-dependent variants in cells and 2D neural cultures. Overall, the results of this study emphasize the importance of HS binding in EV71 pathogenesis and open new avenues for the development of antiviral molecules that may prevent this virus's dissemination.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Tseligka</LastName><ForeName>Eirini D</ForeName><Initials>ED</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Molecular Medicine, University of Geneva Medical School, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sobo</LastName><ForeName>Komla</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Molecular Medicine, University of Geneva Medical School, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Stoppini</LastName><ForeName>Luc</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Tissue Engineering Laboratory, HES-SO/University of Applied Sciences, Geneva, Western Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cagno</LastName><ForeName>Valeria</ForeName><Initials>V</Initials><Identifier Source="ORCID">0000-0002-5597-334X</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Molecular Medicine, University of Geneva Medical School, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Abdul</LastName><ForeName>Fabien</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Molecular Medicine, University of Geneva Medical School, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Piuz</LastName><ForeName>Isabelle</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Microbiology and Molecular Medicine, University of Geneva Medical School, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meylan</LastName><ForeName>Pascal</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Institute of Microbiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Song</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Epithelix S&#xe0;rl, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Constant</LastName><ForeName>Samuel</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Epithelix S&#xe0;rl, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tapparel</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-0411-6567</Identifier><AffiliationInfo><Affiliation>Department of Microbiology and Molecular Medicine, University of Geneva Medical School, Geneva, Switzerland.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>08</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS Pathog</MedlineTA><NlmUniqueID>101238921</NlmUniqueID><ISSNLinking>1553-7366</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D036022">Capsid Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051907">Lysosomal Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D051116">Receptors, Scavenger</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C074299">SCARB2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>9050-30-0</RegistryNumber><NameOfSubstance UI="D006497">Heparitin Sulfate</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D036022" MajorTopicYN="N">Capsid Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName><QualifierName UI="Q000502" MajorTopicYN="Y">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006497" MajorTopicYN="N">Heparitin Sulfate</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051907" MajorTopicYN="N">Lysosomal Membrane Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051116" MajorTopicYN="N">Receptors, Scavenger</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D056189" MajorTopicYN="N">Viral Tropism</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>SH and SC are employees of Epithelix S&#xe0;rl. There is no other relevant information linked to this affiliation that presents any conflict of interest. Moreover, we confirm that this affiliation does not alter our adherence to all PLOS Pathogens policies on sharing data and materials.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2017</Year><Month>10</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>6</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>8</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>8</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30075025</ArticleId><ArticleId IdType="pmc">PMC6093697</ArticleId><ArticleId IdType="doi">10.1371/journal.ppat.1007190</ArticleId><ArticleId IdType="pii">PPATHOGENS-D-17-02324</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Brown BA, Pallansch MA. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 1995;39(2&#x2013;3):195&#x2013;205. .</Citation><ArticleIdList><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Melnick JL. Enterovirus type 71 infections: a varied clinical pattern sometimes mimicking paralytic poliomyelitis. Rev Infect Dis. 1984;6 Suppl 2:S387&#x2013;90. .</Citation><ArticleIdList><ArticleId IdType="pubmed">6330839</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Velez CM, Anderson MS, Robinson CC, McFarland EJ, Nix WA, Pallansch MA, et al. Outbreak of neurologic enterovirus type 71 disease: a diagnostic challenge. Clin Infect Dis. 2007;45(8):950&#x2013;7. 10.1086/521895 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/521895</ArticleId><ArticleId IdType="pubmed">17879907</ArticleId></ArticleIdList></Reference><Reference><Citation>Chan LG, Parashar UD, Lye MS, Ong FG, Zaki SR, Alexander JP, et al. Deaths of children during an outbreak of hand, foot, and mouth disease in sarawak, malaysia: clinical and pathological characteristics of the disease. For the Outbreak Study Group. Clin Infect Dis. 2000;31(3):678&#x2013;83. 10.1086/314032 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/314032</ArticleId><ArticleId IdType="pubmed">11017815</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY. Enterovirus 71 in Taiwan. Pediatr Neonatol. 2008;49(4):103&#x2013;12. 10.1016/S1875-9572(08)60023-6 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1875-9572(08)60023-6</ArticleId><ArticleId IdType="pubmed">19054914</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M, Chen ER, Hsu KH, Twu SJ, Chen KT, Tsai SF, et al. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N Engl J Med. 1999;341(13):929&#x2013;35. 10.1056/NEJM199909233411301 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu J. Enterovirus 71 infection: a new threat to global public health? Lancet neurology. 2008;7(10):868&#x2013;9. 10.1016/S1474-4422(08)70207-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(08)70207-2</ArticleId><ArticleId IdType="pmc">PMC7128195</ArticleId><ArticleId IdType="pubmed">18848307</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi MH, Wong SC, Lewthwaite P, Cardosa MJ, Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet neurology. 2010;9(11):1097&#x2013;105. Epub 2010/10/23. 10.1016/S1474-4422(10)70209-X .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10(11):778&#x2013;90. Epub 2010/10/22. 10.1016/S1473-3099(10)70194-8 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(10)70194-8</ArticleId><ArticleId IdType="pubmed">20961813</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 2002;26(1):91&#x2013;107. .</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi EE, Phoon MC, Ishak B, Chan SH. Seroepidemiology of human enterovirus 71, Singapore. Emerg Infect Dis. 2002;8(9):995&#x2013;7. 10.3201/eid0809.10.3201/eid0809.010397 ; PubMed Central PMCID: PMCPMC2732542.</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid0809.10.3201/eid0809.010397</ArticleId><ArticleId IdType="pmc">PMC2732542</ArticleId><ArticleId IdType="pubmed">12194783</ArticleId></ArticleIdList></Reference><Reference><Citation>Pallansch MA RR. Enteroviruses: poliovirus, coxsackieviruses, echoviruses, and newer enteroviruses Field Virology. Philadelphia: LippincottWilliams &amp; Wilkins; 2001. p. pp. 723&#x2013;75.</Citation></Reference><Reference><Citation>WHO. A Guide to Clinical Management and Public Health Response for Hand, Foot and Mouth Disease (HFMD). HFMD Guidance2011. p. 71.</Citation></Reference><Reference><Citation>Ong KC, Wong KT. Understanding Enterovirus 71 Neuropathogenesis and Its Impact on Other Neurotropic Enteroviruses. Brain Pathol. 2015;25(5):614&#x2013;24. Epub 2015/08/16. 10.1111/bpa.12279 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bpa.12279</ArticleId><ArticleId IdType="pmc">PMC8029433</ArticleId><ArticleId IdType="pubmed">26276025</ArticleId></ArticleIdList></Reference><Reference><Citation>Anastasina M, Domanska A, Palm K, Butcher S. Human picornaviruses associated with neurological diseases and their neutralization by antibodies. J Gen Virol. 2017;98(6):1145&#x2013;58. 10.1099/jgv.0.000780 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jgv.0.000780</ArticleId><ArticleId IdType="pubmed">28631594</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Fujii K, Koike S. Receptors for enterovirus 71. Emerg Microbes Infect. 2014;3(7):e53 10.1038/emi.2014.49 ; PubMed Central PMCID: PMCPMC4126179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2014.49</ArticleId><ArticleId IdType="pmc">PMC4126179</ArticleId><ArticleId IdType="pubmed">26038749</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S, Yamashita Y, Li J, Hanagata N, Minowa T, Takemura T, et al. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat Med. 2009;15(7):798&#x2013;801. Epub 2009/06/23. 10.1038/nm.1992 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiao XY, Guo L, Huang DY, Chang XL, Qiu QC. Distribution of EV71 receptors SCARB2 and PSGL-1 in human tissues. Virus Res. 2014;190:40&#x2013;52. Epub 2014/07/06. 10.1016/j.virusres.2014.05.007 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.05.007</ArticleId><ArticleId IdType="pubmed">24997419</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K, Nagata N, Sato Y, Ong KC, Wong KT, Yamayoshi S, et al. Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc Natl Acad Sci U S A. 2013;110(36):14753&#x2013;8. 10.1073/pnas.1217563110 ; PubMed Central PMCID: PMCPMC3767555.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1217563110</ArticleId><ArticleId IdType="pmc">PMC3767555</ArticleId><ArticleId IdType="pubmed">23959904</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Shimojima M, Tano Y, Miyamura T, Wakita T, Shimizu H. Human P-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat Med. 2009;15(7):794&#x2013;7. 10.1038/nm.1961 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y, Lee H, Hafenstein S, Kataoka C, Wakita T, Bergelson JM, et al. Enterovirus 71 binding to PSGL-1 on leukocytes: VP1-145 acts as a molecular switch to control receptor interaction. PLoS Pathog. 2013;9(7):e1003511 10.1371/journal.ppat.1003511 ; PubMed Central PMCID: PMCPMC3723564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003511</ArticleId><ArticleId IdType="pmc">PMC3723564</ArticleId><ArticleId IdType="pubmed">23935488</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Poh CL, Sam IC, Chan YF. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J Virol. 2013;87(1):611&#x2013;20. Epub 2012/10/26. 10.1128/JVI.02226-12 ; PubMed Central PMCID: PMC3536405.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02226-12</ArticleId><ArticleId IdType="pmc">PMC3536405</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang B, Chuang H, Yang KD. Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells. Virol J. 2009;6:141 10.1186/1743-422X-6-141 ; PubMed Central PMCID: PMC2751754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-6-141</ArticleId><ArticleId IdType="pmc">PMC2751754</ArticleId><ArticleId IdType="pubmed">19751532</ArticleId></ArticleIdList></Reference><Reference><Citation>Su PY, Wang YF, Huang SW, Lo YC, Wang YH, Wu SR, et al. Cell surface nucleolin facilitates enterovirus 71 binding and infection. J Virol. 2015;89(8):4527&#x2013;38. 10.1128/JVI.03498-14 ; PubMed Central PMCID: PMC4442404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03498-14</ArticleId><ArticleId IdType="pmc">PMC4442404</ArticleId><ArticleId IdType="pubmed">25673703</ArticleId></ArticleIdList></Reference><Reference><Citation>Du N, Cong H, Tian H, Zhang H, Zhang W, Song L, et al. Cell surface vimentin is an attachment receptor for enterovirus 71. J Virol. 2014;88(10):5816&#x2013;33. 10.1128/JVI.03826-13 ; PubMed Central PMCID: PMCPMC4019121.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03826-13</ArticleId><ArticleId IdType="pmc">PMC4019121</ArticleId><ArticleId IdType="pubmed">24623428</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SL, Chou YT, Wu CN, Ho MS. Annexin II binds to capsid protein VP1 of enterovirus 71 and enhances viral infectivity. J Virol. 2011;85(22):11809&#x2013;20. 10.1128/JVI.00297-11 ; PubMed Central PMCID: PMCPMC3209289.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00297-11</ArticleId><ArticleId IdType="pmc">PMC3209289</ArticleId><ArticleId IdType="pubmed">21900167</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen P, Song Z, Qi Y, Feng X, Xu N, Sun Y, et al. Molecular determinants of enterovirus 71 viral entry: cleft around GLN-172 on VP1 protein interacts with variable region on scavenge receptor B 2. J Biol Chem. 2012;287(9):6406&#x2013;20. Epub 2012/01/06. 10.1074/jbc.M111.301622 ; PubMed Central PMCID: PMC3307280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.301622</ArticleId><ArticleId IdType="pmc">PMC3307280</ArticleId><ArticleId IdType="pubmed">22219187</ArticleId></ArticleIdList></Reference><Reference><Citation>Victorio CB, Xu Y, Ng Q, Meng T, Chow VT, Chua KB. Cooperative effect of the VP1 amino acids 98E, 145A and 169F in the productive infection of mouse cell lines by enterovirus 71 (BS strain). Emerg Microbes Infect. 2016;5:e60 10.1038/emi.2016.56 ; PubMed Central PMCID: PMCPMC4932649.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emi.2016.56</ArticleId><ArticleId IdType="pmc">PMC4932649</ArticleId><ArticleId IdType="pubmed">27329847</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan CW, Sam IC, Lee VS, Wong HV, Chan YF. VP1 residues around the five-fold axis of enterovirus A71 mediate heparan sulfate interaction. Virology. 2017;501:79&#x2013;87. 10.1016/j.virol.2016.11.009 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2016.11.009</ArticleId><ArticleId IdType="pubmed">27875780</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee H, Cifuente JO, Ashley RE, Conway JF, Makhov AM, Tano Y, et al. A strain-specific epitope of enterovirus 71 identified by cryo-electron microscopy of the complex with fab from neutralizing antibody. J Virol. 2013;87(21):11363&#x2013;70. 10.1128/JVI.01926-13 ; PubMed Central PMCID: PMCPMC3807339.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01926-13</ArticleId><ArticleId IdType="pmc">PMC3807339</ArticleId><ArticleId IdType="pubmed">23946455</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K, Sudaka Y, Takashino A, Kobayashi K, Kataoka C, Suzuki T, et al. VP1 amino acid residue 145 of enterovirus 71 is a key residue for its receptor attachment and resistance to neutralizing antibody during cynomolgus monkey infection. J Virol. 2018. 10.1128/JVI.00682-18 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00682-18</ArticleId><ArticleId IdType="pmc">PMC6052295</ArticleId><ArticleId IdType="pubmed">29848582</ArticleId></ArticleIdList></Reference><Reference><Citation>Kataoka C, Suzuki T, Kotani O, Iwata-Yoshikawa N, Nagata N, Ami Y, et al. The Role of VP1 Amino Acid Residue 145 of Enterovirus 71 in Viral Fitness and Pathogenesis in a Cynomolgus Monkey Model. PLoS Pathog. 2015;11(7):e1005033 10.1371/journal.ppat.1005033 ; PubMed Central PMCID: PMCPMC4504482.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1005033</ArticleId><ArticleId IdType="pmc">PMC4504482</ArticleId><ArticleId IdType="pubmed">26181772</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaini Z, McMinn P. A single mutation in capsid protein VP1 (Q145E) of a genogroup C4 strain of human enterovirus 71 generates a mouse-virulent phenotype. J Gen Virol. 2012;93(Pt 9):1935&#x2013;40. 10.1099/vir.0.043893-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.043893-0</ArticleId><ArticleId IdType="pubmed">22647370</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K, Sudaka Y, Takashino A, Imura A, Fujii K, Koike S. Amino acid variation at VP1-145 of enterovirus 71 determines attachment receptor usage and neurovirulence in human scavenger receptor B2 transgenic mice. J Virol. 2018. 10.1128/JVI.00681-18 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00681-18</ArticleId><ArticleId IdType="pmc">PMC6052303</ArticleId><ArticleId IdType="pubmed">29848584</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang SC, Li WC, Chen GW, Tsao KC, Huang CG, Huang YC, et al. Genetic characterization of enterovirus 71 isolated from patients with severe disease by comparative analysis of complete genomes. J Med Virol. 2012;84(6):931&#x2013;9. 10.1002/jmv.23287 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.23287</ArticleId><ArticleId IdType="pubmed">22499017</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang B, Wu X, Huang K, Li L, Zheng L, Wan C, et al. The variations of VP1 protein might be associated with nervous system symptoms caused by enterovirus 71 infection. BMC Infect Dis. 2014;14:243 10.1186/1471-2334-14-243 ; PubMed Central PMCID: PMCPMC4101859.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-14-243</ArticleId><ArticleId IdType="pmc">PMC4101859</ArticleId><ArticleId IdType="pubmed">24886383</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, Fu C, Wu S, Chen X, Shi Y, Zhou B, et al. A novel finding for enterovirus virulence from the capsid protein VP1 of EV71 circulating in mainland China. Virus Genes. 2014;48(2):260&#x2013;72. 10.1007/s11262-014-1035-2 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11262-014-1035-2</ArticleId><ArticleId IdType="pubmed">24442718</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R, Zou Q, Chen L, Zhang H, Wang Y. Molecular analysis of virulent determinants of enterovirus 71. PLoS ONE. 2011;6(10):e26237 Epub 2011/11/01. 10.1371/journal.pone.0026237 ; PubMed Central PMCID: PMC3198388.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0026237</ArticleId><ArticleId IdType="pmc">PMC3198388</ArticleId><ArticleId IdType="pubmed">22039449</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordey S, Petty TJ, Schibler M, Martinez Y, Gerlach D, van Belle S, et al. Identification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infection. PLoS Pathog. 2012;8(7):e1002826 Epub 2012/08/23. 10.1371/journal.ppat.1002826 ; PubMed Central PMCID: PMC3406088.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002826</ArticleId><ArticleId IdType="pmc">PMC3406088</ArticleId><ArticleId IdType="pubmed">22910880</ArticleId></ArticleIdList></Reference><Reference><Citation>Essaidi-Laziosi M, Brito F, Benaoudia S, Royston L, Cagno V, Fernandes-Rocha M, et al. Propagation of respiratory viruses in human airway epithelia reveals persistent virus-specific signatures. J Allergy Clin Immunol. 2017. 10.1016/j.jaci.2017.07.018 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2017.07.018</ArticleId><ArticleId IdType="pmc">PMC7112338</ArticleId><ArticleId IdType="pubmed">28797733</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S, Boda B, Vernaz J, Ferreira E, Wiszniewski L, Constant S. Establishment and characterization of an in vitro human small airway model (SmallAir). Eur J Pharm Biopharm. 2017;118:68&#x2013;72. 10.1016/j.ejpb.2016.12.006 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejpb.2016.12.006</ArticleId><ArticleId IdType="pubmed">28040470</ArticleId></ArticleIdList></Reference><Reference><Citation>Royston L, Essaidi-Laziosi M, Perez-Rodriguez FJ, Piuz I, Geiser J, Krause KH, et al. Viral chimeras decrypt the role of enterovirus capsid proteins in viral tropism, acid sensitivity and optimal growth temperature. PLoS Pathog. 2018;14(4):e1006962 10.1371/journal.ppat.1006962 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006962</ArticleId><ArticleId IdType="pmc">PMC5908207</ArticleId><ArticleId IdType="pubmed">29630666</ArticleId></ArticleIdList></Reference><Reference><Citation>Antona D, Kossorotoff M, Schuffenecker I, Mirand A, Leruez-Ville M, Bassi C, et al. Severe paediatric conditions linked with EV-A71 and EV-D68, France, May to October 2016. Euro surveillance: bulletin europeen sur les maladies transmissibles = European communicable disease bulletin. 2016;21(46). 10.2807/1560-7917.ES.2016.21.46.30402 ; PubMed Central PMCID: PMCPMC5144948.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2016.21.46.30402</ArticleId><ArticleId IdType="pmc">PMC5144948</ArticleId><ArticleId IdType="pubmed">27918268</ArticleId></ArticleIdList></Reference><Reference><Citation>Karrasch M, Fischer E, Scholten M, Sauerbrei A, Henke A, Renz DM, et al. A severe pediatric infection with a novel enterovirus A71 strain, Thuringia, Germany. J Clin Virol. 2016;84:90&#x2013;5. 10.1016/j.jcv.2016.09.007 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2016.09.007</ArticleId><ArticleId IdType="pubmed">27771495</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang W, Yang H, Kong X, Mohapatra S, San Juan-Vergara H, Hellermann G, et al. Inhibition of respiratory syncytial virus infection with intranasal siRNA nanoparticles targeting the viral NS1 gene. Nat Med. 2005;11(1):56&#x2013;62. 10.1038/nm1174 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1174</ArticleId><ArticleId IdType="pubmed">15619625</ArticleId></ArticleIdList></Reference><Reference><Citation>Bode L, Salvestrini C, Park PW, Li JP, Esko JD, Yamaguchi Y, et al. Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function. J Clin Invest. 2008;118(1):229&#x2013;38. Epub 2007/12/08. 10.1172/JCI32335 ; PubMed Central PMCID: PMCPMC2117765.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI32335</ArticleId><ArticleId IdType="pmc">PMC2117765</ArticleId><ArticleId IdType="pubmed">18064305</ArticleId></ArticleIdList></Reference><Reference><Citation>Sa-Carvalho D, Rieder E, Baxt B, Rodarte R, Tanuri A, Mason PW. Tissue culture adaptation of foot-and-mouth disease virus selects viruses that bind to heparin and are attenuated in cattle. J Virol. 1997;71(7):5115&#x2013;23. ; PubMed Central PMCID: PMCPMC191746.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC191746</ArticleId><ArticleId IdType="pubmed">9188578</ArticleId></ArticleIdList></Reference><Reference><Citation>Prestwood TR, Prigozhin DM, Sharar KL, Zellweger RM, Shresta S. A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads. J Virol. 2008;82(17):8411&#x2013;21. 10.1128/JVI.00611-08 ; PubMed Central PMCID: PMCPMC2519668.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00611-08</ArticleId><ArticleId IdType="pmc">PMC2519668</ArticleId><ArticleId IdType="pubmed">18562532</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferguson MC, Saul S, Fragkoudis R, Weisheit S, Cox J, Patabendige A, et al. Ability of the Encephalitic Arbovirus Semliki Forest Virus To Cross the Blood-Brain Barrier Is Determined by the Charge of the E2 Glycoprotein. J Virol. 2015;89(15):7536&#x2013;49. 10.1128/JVI.03645-14 ; PubMed Central PMCID: PMCPMC4505677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03645-14</ArticleId><ArticleId IdType="pmc">PMC4505677</ArticleId><ArticleId IdType="pubmed">25972559</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva LA, Khomandiak S, Ashbrook AW, Weller R, Heise MT, Morrison TE, et al. A single-amino-acid polymorphism in Chikungunya virus E2 glycoprotein influences glycosaminoglycan utilization. J Virol. 2014;88(5):2385&#x2013;97. 10.1128/JVI.03116-13 ; PubMed Central PMCID: PMCPMC3958064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03116-13</ArticleId><ArticleId IdType="pmc">PMC3958064</ArticleId><ArticleId IdType="pubmed">24371059</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y, Pfeiffer JK. Emergence of a Large-Plaque Variant in Mice Infected with Coxsackievirus B3. MBio. 2016;7(2):e00119 10.1128/mBio.00119-16 ; PubMed Central PMCID: PMCPMC4817249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.00119-16</ArticleId><ArticleId IdType="pmc">PMC4817249</ArticleId><ArticleId IdType="pubmed">27025249</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryman KD, Gardner CL, Burke CW, Meier KC, Thompson JM, Klimstra WB. Heparan sulfate binding can contribute to the neurovirulence of neuroadapted and nonneuroadapted Sindbis viruses. J Virol. 2007;81(7):3563&#x2013;73. 10.1128/JVI.02494-06 ; PubMed Central PMCID: PMCPMC1866052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02494-06</ArticleId><ArticleId IdType="pmc">PMC1866052</ArticleId><ArticleId IdType="pubmed">17215278</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SW, Huang YH, Tsai HP, Kuo PH, Wang SM, Liu CC, et al. A Selective Bottleneck Shapes the Evolutionary Mutant Spectra of Enterovirus A71 during Viral Dissemination in Humans. J Virol. 2017;91(23). 10.1128/JVI.01062-17 ; PubMed Central PMCID: PMCPMC5686718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01062-17</ArticleId><ArticleId IdType="pmc">PMC5686718</ArticleId><ArticleId IdType="pubmed">28931688</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthur Huang KY, Chen MF, Huang YC, Shih SR, Chiu CH, Lin JJ, et al. Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children. Nat Commun. 2017;8(1):762 10.1038/s41467-017-00736-9 ; PubMed Central PMCID: PMCPMC5624920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00736-9</ArticleId><ArticleId IdType="pmc">PMC5624920</ArticleId><ArticleId IdType="pubmed">28970483</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SW, Tai CH, Fonville JM, Lin CH, Wang SM, Liu CC, et al. Mapping Enterovirus A71 Antigenic Determinants from Viral Evolution. J Virol. 2015;89(22):11500&#x2013;6. 10.1128/JVI.02035-15 ; PubMed Central PMCID: PMCPMC4645677.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02035-15</ArticleId><ArticleId IdType="pmc">PMC4645677</ArticleId><ArticleId IdType="pubmed">26339057</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi L, Lu J, Kung HF, He ML. The virology and developments toward control of human enterovirus 71. Critical reviews in microbiology. 2011;37(4):313&#x2013;27. Epub 2011/06/10. 10.3109/1040841X.2011.580723 .</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/1040841X.2011.580723</ArticleId><ArticleId IdType="pubmed">21651436</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaoutis T, Klein JD. Enterovirus infections. Pediatr Rev. 1998;19(6):183&#x2013;91. .</Citation><ArticleIdList><ArticleId IdType="pubmed">9613170</ArticleId></ArticleIdList></Reference><Reference><Citation>Abzug MJ. The enteroviruses: problems in need of treatments. The Journal of infection. 2014;68 Suppl 1:S108&#x2013;14. 10.1016/j.jinf.2013.09.020 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2013.09.020</ArticleId><ArticleId IdType="pubmed">24119825</ArticleId></ArticleIdList></Reference><Reference><Citation>Schibler M, Gerlach D, Martinez Y, Belle SV, Turin L, Kaiser L, et al. Experimental human rhinovirus and enterovirus interspecies recombination. J Gen Virol. 2012;93(Pt 1):93&#x2013;101. 10.1099/vir.0.035808-0 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.035808-0</ArticleId><ArticleId IdType="pubmed">21940413</ArticleId></ArticleIdList></Reference><Reference><Citation>Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. Am J Hyg. 1938;(27):493&#x2013;7.</Citation></Reference><Reference><Citation>Schibler M, Yerly S, Vieille G, Docquier M, Turin L, Kaiser L, et al. Critical analysis of rhinovirus RNA load quantification by real-time reverse transcription-PCR. J Clin Microbiol. 2012;50(9):2868&#x2013;72. Epub 2012/06/22. 10.1128/JCM.06752-11 ; PubMed Central PMCID: PMC3421824.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JCM.06752-11</ArticleId><ArticleId IdType="pmc">PMC3421824</ArticleId><ArticleId IdType="pubmed">22718934</ArticleId></ArticleIdList></Reference><Reference><Citation>Zufferey R, Nagy D, Mandel RJ, Naldini L, Trono D. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat Biotechnol. 1997;15(9):871&#x2013;5. 10.1038/nbt0997-871 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt0997-871</ArticleId><ArticleId IdType="pubmed">9306402</ArticleId></ArticleIdList></Reference><Reference><Citation>Tapparel C, Sobo K, Constant S, Huang S, Van Belle S, Kaiser L. Growth and characterization of different human rhinovirus C types in three-dimensional human airway epithelia reconstituted in vitro. Virology. 2013;446(1&#x2013;2):1&#x2013;8. 10.1016/j.virol.2013.06.031 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2013.06.031</ArticleId><ArticleId IdType="pubmed">24074561</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard Josephson and Jonathan M. Auerbach MT, Inc.&#x2014;GlobalStem, Gaithersburg, MD USA 20877. Human Induced Pluripotent Stem cell-derived neurons as a reproducible system for drug discovery. Stem Cell Symposium; Maryland2014.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>